Cargando…
Synergistic sequence contributions bias glycation outcomes
The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175500/ https://www.ncbi.nlm.nih.gov/pubmed/34083524 http://dx.doi.org/10.1038/s41467-021-23625-8 |
_version_ | 1783703064052498432 |
---|---|
author | McEwen, Joseph M. Fraser, Sasha Guir, Alexxandra L. Sosa Dave, Jaydev Scheck, Rebecca A. |
author_facet | McEwen, Joseph M. Fraser, Sasha Guir, Alexxandra L. Sosa Dave, Jaydev Scheck, Rebecca A. |
author_sort | McEwen, Joseph M. |
collection | PubMed |
description | The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with specific AGEs. Here, we use a combinatorial peptide library to determine the chemical features that favor MGH-1. When properly positioned, tyrosine is found to play an active mechanistic role that facilitates MGH-1 formation. This work offers mechanistic insight connecting multiple AGEs, including MGH-1 and carboxyethylarginine (CEA), and reconciles the role of negative charge in influencing glycation outcomes. Further, this study provides clear evidence that glycation outcomes can be influenced through long- or medium-range cooperative interactions. This work demonstrates that these chemical features also predictably template selective glycation on full-length protein targets expressed in mammalian cells. This information is vital for developing methods that control glycation in living cells and will enable the study of glycation as a functional post-translational modification. |
format | Online Article Text |
id | pubmed-8175500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81755002021-06-07 Synergistic sequence contributions bias glycation outcomes McEwen, Joseph M. Fraser, Sasha Guir, Alexxandra L. Sosa Dave, Jaydev Scheck, Rebecca A. Nat Commun Article The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with specific AGEs. Here, we use a combinatorial peptide library to determine the chemical features that favor MGH-1. When properly positioned, tyrosine is found to play an active mechanistic role that facilitates MGH-1 formation. This work offers mechanistic insight connecting multiple AGEs, including MGH-1 and carboxyethylarginine (CEA), and reconciles the role of negative charge in influencing glycation outcomes. Further, this study provides clear evidence that glycation outcomes can be influenced through long- or medium-range cooperative interactions. This work demonstrates that these chemical features also predictably template selective glycation on full-length protein targets expressed in mammalian cells. This information is vital for developing methods that control glycation in living cells and will enable the study of glycation as a functional post-translational modification. Nature Publishing Group UK 2021-06-03 /pmc/articles/PMC8175500/ /pubmed/34083524 http://dx.doi.org/10.1038/s41467-021-23625-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article McEwen, Joseph M. Fraser, Sasha Guir, Alexxandra L. Sosa Dave, Jaydev Scheck, Rebecca A. Synergistic sequence contributions bias glycation outcomes |
title | Synergistic sequence contributions bias glycation outcomes |
title_full | Synergistic sequence contributions bias glycation outcomes |
title_fullStr | Synergistic sequence contributions bias glycation outcomes |
title_full_unstemmed | Synergistic sequence contributions bias glycation outcomes |
title_short | Synergistic sequence contributions bias glycation outcomes |
title_sort | synergistic sequence contributions bias glycation outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175500/ https://www.ncbi.nlm.nih.gov/pubmed/34083524 http://dx.doi.org/10.1038/s41467-021-23625-8 |
work_keys_str_mv | AT mcewenjosephm synergisticsequencecontributionsbiasglycationoutcomes AT frasersasha synergisticsequencecontributionsbiasglycationoutcomes AT guiralexxandralsosa synergisticsequencecontributionsbiasglycationoutcomes AT davejaydev synergisticsequencecontributionsbiasglycationoutcomes AT scheckrebeccaa synergisticsequencecontributionsbiasglycationoutcomes |